Helixmith Co., Ltd.

This early-stage trial aimed to test a gene therapy for males with a rare inherited immune disorder called chronic granulomatous disease (CGD). The approach involved collecting a patient's own blood stem cells, using a modified virus to insert a corrected gene into them, and then…

This study aimed to test whether a gene therapy called VM202RY could help the heart heal after a serious heart attack. The treatment involved injecting the therapy directly into the heart muscle of eligible patients to try to improve blood flow and heart function. The trial was d…

This early-phase study aimed to test the safety of an experimental gene therapy called VM202 for people with chronic chest pain who couldn't get standard heart procedures. Researchers planned to inject the therapy directly into the heart using a special catheter to see if it coul…

This study aimed to test if a dietary supplement called TADIOS could help people with mild to moderate COVID-19 recover faster. It planned to give the supplement or a placebo (dummy pill) to 100 hospitalized patients for up to 10 days. The main goals were to see if it reduced sym…

This study aimed to test if a tablet called PG201 could safely reduce pain and improve symptoms in people with knee osteoarthritis. It planned to compare two different doses of the tablet against a placebo (a dummy pill) over 8 weeks. The trial was withdrawn by the sponsor before…